Implementation of solutions to reduce opioid-induced oversedation and respiratory depression

被引:16
|
作者
Meisenberg, Barry [1 ,2 ]
Ness, John [3 ]
Rao, Sumati [3 ]
Rhule, Jane [2 ]
Ley, Cathaleen [4 ]
机构
[1] Anne Arundel Med Ctr, Ctr Hlth Care Improvement, Annapolis, MD 21401 USA
[2] Anne Arundel Med Ctr, Res Inst, Outcomes Dept, Annapolis, MD 21401 USA
[3] Anne Arundel Med Ctr, Dept Pharm, Annapolis, MD USA
[4] Anne Arundel Med Ctr, Dept Nursing Qual & Res, Annapolis, MD USA
关键词
analgesics; opioid; narcosis; narcotics; patient safety; PAIN MANAGEMENT; SEDATION ASSESSMENT; ADVERSE-EVENTS; PATIENT SAFETY; CARE-UNIT; HYDROMORPHONE; ANESTHESIA;
D O I
10.2146/ajhp160208
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose. The implementation of interventions to mitigate the causes of opioid-induced oversedation and respiratory depression (OSRD) is reported. Summary. A single-site retrospective review of eligible rescue naloxone cases was conducted to identify the causes of opioid-induced OSRD in a hospital as well as to identify risk factors. A survey was used to assess potential opioid knowledge deficits among hospitalist prescribers. Based on the findings of the case reviews and results of the opioid knowledge assessments, a series of interventions to address noted deficiencies was implemented over the ensuing months, including enhanced monitoring for sedation, improved clinical decision support in the electronic medical record (EMR), and various adjustments to dosing for high-risk patients. The primary endpoint of our analysis was naloxone use for documented cases of opioid-induced OSRD to determine the effectiveness of the interventions. A mean of 16 OSRD events occurred per quarter before intervention implementation. An average of five risk factors (range, two to six) was found among OSRD cases, most commonly age of >60, obesity, and comorbidities of the kidneys and lungs. Deficiencies of clinical care were found in four inter-related domains: knowledge deficits, inadequate monitoring, failure to leverage the EMR, and cultural issues regarding pain assessments and sedation management. Conclusion. Implementation of solution bundles that utilized an EMR to create meaningful clinical decision support and cultural changes related to pain goals and communication about sedation level at an acute care hospital resulted in a fivefold reduction in OSRD events that has been sustained for two years.
引用
收藏
页码:162 / 169
页数:8
相关论文
共 50 条
  • [31] SIDE-EFFECTS OF NALBUPHINE WHILE REVERSING OPIOID-INDUCED RESPIRATORY DEPRESSION - REPORT OF 4 CASES
    BLAISE, GA
    NUGENT, M
    MCMICHAN, JC
    DURANT, PAC
    CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 1990, 37 (07): : 794 - 797
  • [32] Avoiding Adverse Events Secondary to Opioid-Induced Respiratory Depression Implications for Nurse Executives and Patient Safety
    Jungquist, Carla R.
    Correll, Darin J.
    Fleisher, Lee A.
    Gross, Jeffrey
    Gupta, Rajnish
    Pasero, Chris
    Stoelting, Robert
    Polomano, Rosemary
    JOURNAL OF NURSING ADMINISTRATION, 2016, 46 (02): : 87 - 94
  • [33] Quality improvement project to reduce perioperative opioid oversedation events in a paediatric hospital
    Vermaire, Deborah
    Caruso, Michelle C.
    Lesko, Anne
    Kloppenborg, Elizabeth
    Olivea, Jason
    Pruett, Raymond
    Paul, Marika
    Schoettker, Pamela J.
    Seid, Michael
    Varadarajan, Kartik R.
    Conway, Patrick H.
    BMJ QUALITY & SAFETY, 2011, 20 (10) : 895 - 902
  • [34] Risk factors for opioid-induced respiratory depression in surgical patients: a systematic review and meta-analyses
    Gupta, Kapil
    Nagappa, Mahesh
    Prasad, Arun
    Abrahamyan, Lusine
    Wong, Jean
    Weingarten, Toby N.
    Chung, Frances
    BMJ OPEN, 2018, 8 (12):
  • [35] Economic and clinical burden of opioid-induced nausea and vomiting
    Nicholson, Bruce D.
    POSTGRADUATE MEDICINE, 2017, 129 (01) : 111 - 117
  • [36] Opioid-induced sexual dysfunction in men
    Salata, Bartlomiej
    Toczek-Wasiak, Agnieszka
    Kluczna, Agnieszka
    Dzierzanowski, Tomasz
    MEDYCYNA PALIATYWNA-PALLIATIVE MEDICINE, 2022, 14 (02): : 72 - 80
  • [37] Knowledge of opioid-induced respiratory depression among Chinese health care professionals: A cross-sectional study
    Li, Xin
    Li, Na
    Lu, Yuhan
    Ma, Xiaoxiao
    Yang, Hong
    Sun, Hong
    Chen, Fan
    ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING, 2022, 9 (01) : 55 - 60
  • [38] Fact vs. fiction: naloxone in the treatment of opioid-induced respiratory depression in the current era of synthetic opioids
    Dahan, Albert
    Franko, Thomas S.
    Carroll, James W.
    Craig, David S.
    Crow, Callie
    Galinkin, Jeffrey L.
    Garrity, Justin C.
    Peterson, Joanne
    Rausch, David B.
    FRONTIERS IN PUBLIC HEALTH, 2024, 12
  • [39] Are thyrotropin-releasing hormone (TRH) and analog taltirelin viable reversal agents of opioid-induced respiratory depression?
    Algera, Marieke Hyke
    Cotten, Joseph F.
    van Velzen, Monique
    Niesters, Marieke
    Boon, Martijn
    Shoham, Daniel S.
    Dandrea, Kaye E.
    van der Schrier, Rutger
    Dahan, Albert
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2022, 10 (03):
  • [40] Development of a Risk Index for Serious Prescription Opioid-Induced Respiratory Depression or Overdose in Veterans' Health Administration Patients
    Zedler, Barbara
    Xie, Lin
    Wang, Li
    Joyce, Andrew
    Vick, Catherine
    Brigham, Janet
    Kariburyo, Furaha
    Baser, Onur
    Murrelle, Lenn
    PAIN MEDICINE, 2015, 16 (08) : 1566 - 1579